|Articles|March 1, 1996
Supplements and Featured Publications
- Calcium Channel Blockers: 1995 -- The Year in Review
- Volume 2
- Issue 4 Suppl
Update - January 1996: FDA Does Not Support Labeling Changes to Calcium Antagonists Other Than Immediate-Release Nifedipine
Advertisement
Articles in this issue
over 30 years ago
Calcium Channel Blockers: 1995 - An Overviewover 30 years ago
Safety of Calcium Channel Blockers: Results of Recent Trialsover 30 years ago
Calcium Channel Blockers: New Trials and Trials in Progressover 30 years ago
Are Calcium Channel Blockers Prohemorrhagic?over 30 years ago
A Provocative Interpretation of the Case Control Analysisover 30 years ago
Shades of Opinion: What Is Prudent?over 30 years ago
ParticipantsAdvertisement
Advertisement
Advertisement
Trending on AJMC
1
COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV
2
Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure
3
Real-World Data Show MASH Progresses Faster Than Trials Suggest
4
Sarcoma's Rarity Limits Trials and Biomarker-Driven Treatment Options: Alexander Spira, MD, PhD, FACP, FASCO
5